AvKARE, LLC is a trusted source for generic pharmaceuticals and infection control products for the government and commercial sectors. The company is a manufacturer of unit dose, unit of use, and bulk products that are utilized in hospital pharmacies to retail pharmacies across the nation. AvKARE proudly holds many GPO, FSS, and national contracts. They serve the DOD, VA, VHA, NIH, CDC, HHS, all US Armed Forces, State, local, and unique commercial customers. Their latest introduction is AvKARE’s very own line of infection control products. Overall, AvKARE, LLC appears to be a significant player in the pharmaceutical and infection control product industry, with a focus on serving government and commercial sectors. The company's extensive contracts and partnerships, including with the DOD, VA, VHA, NIH, and CDC, demonstrate its credibility and reach within the market. The introduction of their own line of infection control products further showcases their commitment to innovation and addressing current market demands. It's important to note that as of now, there is no public information available regarding the last investment or the last investment investors. However, given the nature of their operations and the sector they operate in, AvKARE, LLC could be an attractive prospect for potential investment opportunities, especially given their established presence and partnerships within the government and commercial sectors. With an increasing focus on healthcare and infection control, there may be potential for further growth and expansion for AvKARE, LLC in the future.
There is no investment information
No recent news or press coverage available for AvKARE, LLC.